SOUTH SAN FRANCISCO, Calif., Nov. 20, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Lewis T. "Rusty" Williams, MD, PhD, President and Chief Executive Officer of Five Prime, will present at the 25th Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2013 at the New York Palace Hotel in New York City at 11:30 a.m. (Eastern Time).
To access the live webcast of the presentation please visit the "Events & Presentations" page under the "Investors" tab on Five Prime's website or access the webcast directly at http://www.media-server.com/m/p/7tzjztzn. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
About Five Prime
Five Prime is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,600 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets for protein therapeutics. Additional information can be found at the company's website: www.fiveprime.com.
CONTACT: Amy Kendall Corporate Communications 415-365-5776 firstname.lastname@example.org
Source:Five Prime Therapeutics, Inc.